Media Coverage

March 24, 2024

Destiny Pharma’s Chairman, Sir Nigel Rudd, receives Lifetime Achievement Award at the ...

March 9, 2024

Destiny Pharma featured in Daily Mail – 9th March 2024

October 29, 2023

Destiny Pharma featured in the Mail on Sunday – 29th October 2023

April 13, 2023

Neil Clark of Destiny Pharma: Our number one target is a deal on XF-73 this year – Vox...

April 2023

Destiny Pharma CSO discusses breakthrough treatment for C. difficile infection

March 24, 2023

Neil Clark of Destiny Pharma discusses XF-73’s significant Phase 2 data published in a...

March 6, 2023

Neil Clark updates Proactive Investors on progress

February 24, 2023

Neil Clark & Shaun Claydon of Destiny Pharma: Collaboration for NTCD-M3 worth up to...

November 23, 2022

Neil Clark speaks to Labiotech about Antimicrobial Resistance

November 18, 2022

Bill Love speaks to Proactive Investors on addressing the Global Threat of superbugs and...